Category: Prescription Drugs
China Prescription Drugs
-
Osteoporosis Drugs Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Top 5 Emerging Countries Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027
... to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights These countries contributed $288.2 billion to the global pharmaceuticals industry ... Read More
-
BRIC Countries (Brazil, Russia, India, China) Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027
... forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights Brazil, Russian Federation, India and China (BRIC) are the ... Read More
-
China Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 13.73 billion by 2028, growing at a CAGR of 2.70% during the forecast period (2023-2028). According to WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 ... Read More
-
Moderate and Severe Dry Eye Disease Market in China 2023
... can cause discomfort, irritation, and even vision problems. The severity of dry eye disease can range from mild to moderate to severe, depending on the extent of the symptoms and the impact on daily life. ... Read More
-
China Healthcare Supply Chain Management Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the China market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the China market. Also, factors that are driving and restraining the healthcare supply chain management ... Read More
-
China COPD & Asthma Market 2022-2028
... setting and Clinics Center) Forecast Period (2021-2028) The China Chronic obstructive pulmonary disease (COPD) & asthma market was valued at around $3.5 billion in 2021 and is estimated to reach nearly $4.7 billion in 2028, ... Read More
-
CHINA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 COVID-19 fatalities. Diabetes affects about one out of every ten COVID-19 patients in China. Diabetes is linked to an increased ... Read More
-
Investigation Report on China's Infliximab Market 2022-2031
... a variety of autoimmune diseases, including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and ankylosing spondylitis. Infliximab was developed by Johnson & Johnson. In 2007, Infliximab entered the Chinese market. The Chinese infliximab market is completely ... Read More
-
Investigation Report on China's Aflibercept Market 2022-2031
... Bayer. Regeneron has exclusive sales rights in the U.S. market, while Bayer obtains exclusive sales rights outside the U.S. Their Aflibercept, EYLEA was launched in China in 2018. By July 2022, Bayer AG is the ... Read More
Research Assistance
